It has also been established that APP and its degradation products localise to neuritic vesicles [26] in the axons of AD brains, along with other neurodegenerative diseases, suggesting that APP accumulation may represent a hallmark of axonal injury [27, 28]. The gene discussed is APP; the disease is neurodegenerative disease.